INTRODUCTION
. Insm1 is required for differentiation of endocrine cells in the pancreas and intestine, and its mutation affects the execution of a gene expression program that comprises hormones and secretory proteins (Gierl et al., 2006) . Available evidence indicates that expression of Insm1 can be controlled by transcription factors of the bHLH family such as Mash1, Ngn1 or Ngn3 (Breslin et al., 2003; Castro et al., 2006; Mellitzer et al., 2006) . We investigate here the function of Insm1 in the peripheral nervous system, and demonstrate that Insm1 is a crucial component of the transcriptional network that coordinates the differentiation of sympatho-adrenal cells. Our data indicate that Insm1 genetically acts downstream of Mash1 and Phox2b, and that in addition Insm1 represses Mash1. Furthermore, we show that the fetal lethality of Insm1 mutant mice is caused by insufficient catecholamine synthesis, highlighting the importance of Insm1 in development of the sympatho-adrenal lineage.
MATERIALS AND METHODS

Mouse strains and determination of noradrenaline levels
The generation and genotyping of Insm1 lacZ , Mash1 GFP , and Phox2b lacZ mutant mice were described (Gierl et al., 2006; Pattyn et al., 1999; Wildner et al., 2006) . We observed a pronounced fetal lethality of Insm1 lacZ /Insm1 lacZ mice on a 129/Ola/C57/BL6 genetic background. In order to rescue this fetal lethality pharmacologically, pregnant Insm1 lacZ /+ dams that had been mated to Insm1 lacZ /+ males received L-DOPA (1 mg/ml; 0.25% ascorbic acid) in their drinking water (Thomas et al., 1995) . Rescued animals died shortly after birth. The Insm1 lacZ allele was also crossed for two to three generations onto the CD1 strain, and the fetal lethality was less pronounced on this outbred genetic background (Gierl et al., 2006) . However, changes in development of the sympatho-adrenal lineage were comparable on both genetic backgrounds.
Noradrenaline levels were analyzed essentially as described (Britsch et al., 1998; Thomas et al., 1995) . In short, Insm1 lacZ /+ and Insm1 lacZ /Insm1 lacZ mice at E12.5 were homogenized in 0.1 M perchloric acid, and the protein concentrations in the homogenates were determined (Bio-Rad, Hercules, CA, USA). Catecholamines were purified over alumina columns, and noradrenaline levels were determined by HPLC chromatography (Haema Institute for Laboratory Medicine, Berlin, Germany).
In situ hybridization, X-gal staining, BrdU labeling and immunohistochemistry
For in situ hybridization, embryonic or adult tissues were embedded either in OCT compound or paraffin and sectioned. Hybridization was performed with DIG-labeled riboprobes. Fragments amplified from cDNA were used to generate the RNA probes for Insm1, Chromogranin A and B; other probes were generated from plasmids obtained from various laboratories. Detection of ␤-galactosidase activity by X-gal staining was performed as described previously (Lobe et al., 1999) .
Immunohistochemistry was performed on 12 m cryosections of mouse embryos fixed with 4% paraformaldehyde in 0.1 M sodium phosphate buffer, pH7.4. The following primary antibodies were used: goat anti-␤-galactosidase (1:1000; AbD Serotec, Oxford, UK), rabbit anti-␤-galactosidase (1:1000; ICN Biochemical, Eschwege, Germany), mouse antiMash1 (1:500 BD Biosciences, San Jose, CA, USA), rabbit anti-Th (1:200; Pel-Freez, Rogers, AR, USA), rabbit anti-Phox2a, rabbit anti-Phox2b (both 1:1000; Christo Goridis and Jean-Francois Brunet, Ecole Normale Superieure, Paris, France); rabbit anti-Npy (1:8000; Sigma, St Louis, MO, USA); rabbit anti-p75 (1:200; Promega, Madison, WI, USA), rabbit and guinea-pig anti-Tlx3 (Muller et al., 2005) ; mouse anti-Tuj1 (1:1000, Covance, Berkeley, CA, USA); rabbit anti-Pnmt (1:1000; ImmunoStar, Hudson, WI, USA) and secondary antibodies conjugated with Cy2, Cy3, or Cy5 (1:500; Jackson ImmunoResearch, West Grove, PA, USA). Cell death was determined by TUNEL staining using an Apop-Tag fluorescein in situ apoptosis detection kit (Millipore, Billerica, MA, USA).
For BrdU labeling, BrdU (75 g/g body weight; Sigma) was injected intraperitoneally, and embryos were isolated at the indicated times. Sections were treated with primary antibodies that specifically detect various cell types, and subsequently labeled with anti-BrdU antibodies. Incorporated BrdU was detected with either mouse (1:200; Sigma) or rat anti-BrdU antibodies (1:200; AbD Serotec, Oxford, UK). Fluorescence was imaged on a Zeiss LSM 5 Pascal confocal microscope and images were processed using Adobe Photoshop software.
Cell counts
Cells in the anlage of the sympathetic nervous system were stained with antibodies against ␤-galactosidase, BrdU, Phox2a, Phox2b, Th, Tuj1 or Mash1, and the numbers of double-positive cells were counted on at least three sections obtained from three or four heterozygous and homozygous Insm1 lacZ mice. TUNEL+ cells were counted in the adrenal medulla on sections obtained from three heterozygous and three homozygous Insm1 lacZ mice at E18.5; at least three sections per animal were counted. The numbers of ␤-galactosidase+ cells in the adrenal gland were determined by counting ␤-galactosidase+ cells on cryosections of adrenal glands that were obtained from three heterozygous and three homozygous Insm1 lacZ mice at E14.5, E16.5 and E18.5. The entire adrenal gland was sectioned, and every second (E14.5) or forth section (E16.5 and E18.5) was counted. To assess the statistical significance, a Student's t-test for a two-tailed distribution and a two-sample unequal variance was applied.
Microarray analysis
Adrenal glands were dissected from E18.5 wild-type and Insm1 lacZ /Insm1 lacZ embryos and homogenized in Trizol (Invitrogen, Carlsbad, CA, USA). RNA extraction, probe synthesis and hybridization to Affymetrix MOE430 2.0 microarrays (Affymetrix, Santa Clara, CA, USA) were performed according to the manufacturer's protocol. Data processing and identification of differentially expressed genes was carried out as described (Gierl et al., 2006) . Genes were considered differentially expressed if the difference of their expression level had a P-value of 0.05.
RESULTS
Noradrenaline deficiency causes the fetal lethality of Insm1 mutant mice
We have reported previously that the majority of Insm1 lacZ /Insm1 lacZ mice died during the second half of gestation. On a mixed 129/Ola/C57/BL6 genetic background, 23.8%, 22.5% and 6.5% of the offspring of heterozygous matings had an Insm1 lacZ /Insm1 lacZ genotype at E10.5, E12.5 and P0, respectively (see also Gierl et al., 2006) . Noradrenaline is the major catecholamine produced by developing sympatho-adrenal cells and is required for fetal survival (Britsch et al., 1998; Lim et al., 2000; Pattyn et al., 2000; Thomas et al., 1995; Zhou et al., 1995 mice, indicating that diminished Th and Dbh synthesis were responsible for the low noradrenaline levels (see also below). Alterations in sympathetic activity in Phox2b, Gata3, Th or Dbh mutant mice have been directly linked to fetal lethality apparently caused by heart failure. Fetal lethality can be rescued by feeding catecholamine intermediates or noradrenaline receptor agonists to pregnant dams (Lim et al., 2000; Pattyn et al., 2000; Thomas et al., 1995; Zhou et al., 1995 Insm1 is expressed widely in the differentiating peripheral and central nervous system (Breslin et al., 2003; Gierl et al., 2006) . Here, we used mice carrying one copy of an Insm1 lacZ mutant allele to characterize Insm1 expression, and analyzed the appearance of the lacZ gene product, ␤-galactosidase, in the sympatho-adrenal lineage. We did not detect expression of ␤-galactosidase in migrating neural crest cells that were visualized by anti-p75 antibodies (Fig. 1A) . The first ␤-galactosidase+ cells in the peripheral nervous system appeared around E9.5 and were detected in the anlage of the primary sympathetic ganglion chain lateral of the dorsal aorta on interlimb levels, and in differentiating neurons of the condensing dorsal root ganglia ( Fig. 1A ; see also Fig. S1 in the supplementary material). At E10.5, the entire primary sympathetic ganglion chain expressed ␤-galactosidase, as assessed by X-gal staining (Fig. 1B) . Immunohistological analysis showed that ␤-galactosidase+ cells co-expressed Phox2b, indicating that sympathoadrenal precursor cells express Insm1 (Fig. 1C) . In addition, some but not all ␤-galactosidase+ cells co-expressed Mash1 (Fig. 1D) ; the transient nature of the expression of Mash1 might account for this. Insm1 expression in sympathetic ganglia was observable at E18.5 (data not shown). ␤-Galactosidase expression or Insm1 transcripts were also detected in chromaffin cells of the adrenal gland ( Fig. 1E and data not shown). Expression in the adrenal gland was detected at E13.5, and persisted in the adult adrenal gland.
Insm1 is required for the differentiation of sympatho-adrenal precursor cells
We next investigated the formation and differentiation of the primary sympathetic ganglion chain of Insm1 mutant mice. Neural crest cells that initiate sympatho-adrenal differentiation were identified by in situ hybridization using Phox2b as a probe, and we 475 RESEARCH ARTICLE Insm1 in sympatho-adrenal development Immunohistochemical analysis using anti-␤-galactosidase (green) and anti-p75 (red) antibodies demonstrates expression of ␤-galactosidase in the primary sympathetic ganglion chain located lateral of the dorsal aorta (arrowhead), in the spinal cord and in condensing dorsal root ganglia at E9.5. (B) At E10.5, X-gal staining is detected in the entire primary sympathetic ganglion chain (arrowhead), as well as in sensory ganglia and in the central nervous system. (C,D) Immunohistochemical analyses of the primary sympathetic ganglion chain using antibodies directed against ␤-galactosidase (green), Phox2b (red in C) and Mash1 (red in D) indicate that the majority of ␤-galactosidase+ cells lateral of the dorsal aorta co-express Phox2b, and some ␤-galactosidase+ cells also express Mash1. (E) Immunohistochemical analysis of the adrenal gland at E13.5 using anti-␤-galactosidase (green) and anti-Th (red) antibodies demonstrates Insm1 expression in chromaffin cells of the adrenal medulla. Scale bars: 100 m in A,C,E; 500 m in B. observed Phox2b+ sympatho-adrenal precursors lateral of the dorsal aorta in heterozygous and homozygous Insm1 lacZ mice (Fig. 2) . At E10.5, the size of the primary ganglion chain was comparable when analyzed by Phox2b in situ hybridization, by immunohistochemistry using anti-␤-galactosidase antibodies or by X-gal staining ( Fig. 2A-F Fig. 3A,B) , indicating that the differentiation of sympatho-adrenal progenitor cells is correctly initiated in Insm1 mutant mice. However, at subsequent developmental stages we noted a pronounced reduction in the size of the primary sympathetic ganglion chain in Insm1 lacZ /Insm1 lacZ mice, regardless whether Phox2b in situ hybridization, ␤-galactosidase immunohistochemistry or X-gal staining were used (Fig. 2G-N) . Sympatho-adrenal precursors possess proliferative capacities (Rohrer and Thoenen, 1987) . We compared the proliferation in control and Insm1 mutant mice using BrdU injections, and determined the proportions of ␤-galactosidase+ sympatho-adrenal precursor cells that incorporated BrdU. In control mice, we observed considerable proliferation rates of sympatho-adrenal precursor cells at E11.5 and E12.5, which were reduced in Insm1 lacZ /Insm1 lacZ mice (Fig. 2O) . At E14.5, proliferation rates were comparable in control and Insm1 mutant mice (Fig. 2D) . Apoptosis in cells lateral of the dorsal aorta, as assessed by TUNEL staining, was not augmented at E10.5 and E12.5 (data not shown). We therefore conclude that a reduced proliferation of sympatho-adrenal precursor cells accounts for the reduced size of the primary sympathetic ganglion chain in homozygous Insm1 mutant mice.
We also assessed the expression of genes that appear after Phox2b in the differentiating sympatho-adrenal lineage. We observed that few sympatho-adrenal precursor cells expressed Phox2a, Hand2, Gata3, Ret, Th and Dbh in Insm1 mutant mice at E10.5 (Fig. 3A-N) . Thus, at E10.5, the time point at which the analysis of Phox2b or ␤-galactosidase expression did not reveal a change in the size of the primary ganglion chain of Insm1 mutant mice, many differentiation markers were expressed in only few sympatho-adrenal precursor cells. However, the expression of these genes recovered at later stages. We quantified the proportion of ␤-galactosidase+ sympathoadrenal precursor cells that co-expressed Th at various developmental stages. In control mice at E10.0, 60% of the ␤-galactosidase+ cells expressed Th, but only 10% co-expressed Th in the Insm1 lacZ /Insm1 lacZ mutant animals ( Fig. 3Q-S) . At E14.5, the proportions of co-expressing cells were similar in control and mutant mice (Fig. 3S) . We also observed a delay in the differentiation of the sympatho-adrenal precursor cells when we analyzed Phox2a expression in Insm1 mutant mice ( Fig. 3T-V) . At E10.5, 59% of ␤-galactosidase+ cells co-expressed Phox2a in control mice, but only 13% in the Insm1 lacZ /Insm1 lacZ mutant mice. By contrast, by E12.5 similar proportions of ␤-galactosidase+ cells co-expressed Phox2a in heterozygous and homozygous mutant mice (Fig. 3V) . By (Fig. 3W-Y) . We conclude that proliferation and differentiation of sympatho-adrenal precursor cells are affected by the Insm1 mutation.
Mash1 expression appears early during differentiation of the sympathetic ganglion chain. In situ hybridization demonstrated a markedly upregulated expression of Mash1 at E10.5 in the primary sympathetic ganglion chain of Insm1 mutant mice (Fig. 4A,B) . At this stage, the Mash1 target gene delta-like 1 (Dll1) was also markedly upregulated (Fig. 4C,D) . The expression of genes controlled by Notch signaling, Hes1, Hes5, Hes1r or Nrarp, were not affected (not shown). Upregulated expression of Mash1 was less pronounced at E12.5 (Fig. 4I,J) . Mash1 protein in the primary ganglion chain was also assessed by immunohistochemistry. In heterozygous Insm1 mutant mice, the proportion of ␤-galactosidase+ cells that co-expressed Mash1 was 48% at E10.5, but in homozygous Insm1 mutant mice, the proportion of co-expressing cells was 85% (Fig. 4E,F ). Phox2a and Mash1 were, however, not co-expressed in sympatho-adrenal precursor cells of heterozygous or homozygous Insm1 mutant mice (Fig. 4G,H) .
Sympatho-adrenal precursor cells migrate from the primary ganglion chain to generate secondary sympathetic ganglia. The reduction in the overall size of the primary sympathetic ganglion chain in Insm1 mutant mice at E12.5 was accompanied by a reduced size of secondary sympathetic ganglia at E14.5 and E18.5. Thus, for instance the superior cervical and stellate ganglia were smaller in Insm1 lacZ /Insm1 lacZ than in Insm1 lacZ /+ mice when assessed by whole-mount staining using X-gal (Fig. 5A,B) . Similarly, immunohistochemical analyses of control and mutant stellate ganglia demonstrated a reduction in size when antibodies directed against Tuj1, Th or Phox2a were used (Fig. 5C-H) . However, similar proportions of neurons expressed NPY, Tlx3 and Ret in the secondary sympathetic ganglia of control and mutant mice at E18.5 (Fig. 5C-H and data not shown) , indicating that maturation of sympathetic neurons had occurred.
Differentiation of chromaffin cells in Insm1 mutant mice
Sympatho-adrenal precursor cells move to the anlage of the adrenal gland around E12.5, and by E14.5 their derivatives, the chromaffin cells, can be detected in great numbers in the adrenal medulla (Britsch et al., 1998; Huber et al., 2002) . Chromaffin cells that express ␤-galactosidase were present in comparable numbers in the adrenal medulla of heterozygous and homozygous Insm1 lacZ mutant mice at E14.5, but these cells appeared more dispersed in heterozygous mice ( Fig. 6A,B ; for a quantification 477 RESEARCH ARTICLE Insm1 in sympatho-adrenal development see Q). At E18.5, the numbers of ␤-galactosidase+ cells were reduced by 61% in homozygous Insm1 mutants (Fig. 6Q) We analyzed various genes expressed in differentiating chromaffin cells. Mash1 expression was increased in the adrenal gland of the Insm1 mutant mice at E14.5 and E18.5 (Fig. 6C,D and Table 1 ). By contrast, the expression of genes that encode enzymes responsible for catecholamine biosynthesis like Th, Dbh and the adrenalin-synthesizing enzyme phenylethanolamine Nmethyltransferase (Pnmt) was downregulated (Fig. 6E-L (Table 1 and Fig. 6M-P) . The 2.5-fold reduction in chromaffin cell numbers cannot account for these pronounced changes in transcript levels. In addition, a small number of genes, among them Mash1 and Nf68 (Nefl -Mouse Genome Informatics), were significantly upregulated (Table 1) . By contrast, changes in the transcript level of Phox2a/b, Gata2/3 and Hand2 were small (fold changes of transcript levels between 1.8 and 3.4; see Table 1 ). The remaining chromaffin cells appeared to express similar transcript levels of Phox2a/b, Gata2/3 and Hand2 when analyzed by in situ hybridization (data not shown). Thus, the 2.5-fold reduction in the number of chromaffin cells contributes significantly to the observed downregulation of Phox2a/b, Gata2/3 and Hand2 transcript levels, and might even account for it (compare Fig. 6Q and Table 1 ). Dll1 was not significantly expressed in the adrenal gland of control and mutant mice. We conclude that the terminal differentiation of chromaffin cells is impaired in Insm1 mutant mice, and that gene products essential for catecholamine production and secretion are not correctly expressed.
Epistasis between Insm1, Phox2b and Mash1
Sympatho-adrenal neurons require Phox2b for their differentiation (Pattyn et al., 1999) . We analyzed Insm1 expression in Phox2b mutant mice at E10.5 and E12.5, and detected no Insm1 expression lateral of the dorsal aorta (Fig. 7A-D and data not shown) . This demonstrates that Insm1 expression is indeed restricted to the neuronal population in the developing sympathetic nervous system, and indicates that Phox2b is required to initiate Insm1 expression. In the primary sympathetic ganglion chain of Mash1 mutant mice, Phox2b expression is correctly initiated, but other markers appear delayed (Pattyn et al., 2006) . We observed no Insm1 expression in Mash1 mutant mice at E10.5 in sympatho-adrenal precursors, and at E12.5 expression was downregulated in a pronounced manner (Fig. 7E,F) . Thus, Mash1 is also required for correct Insm1 expression during development of sympatho-adrenal precursors (see Fig. 7G for a summary).
DISCUSSION
Insm1 encodes a Zn-finger factor that is expressed widely in the developing peripheral and central nervous system. In the central nervous system, for example in the spinal cord, neurons express Insm1 for only a short period during their differentiation (Gierl et al., 2006) . Our analyses indicate that Insm1 is dispensable for generic neurogenesis and neuronal specification in spinal cord (H.W., M.S.G. and Thomas Müller, unpublished) . By contrast, neural crestderived sympatho-adrenal precursors express Insm1 for prolonged periods, and require Insm1 for their differentiation. In particular, differentiation of sympatho-adrenal precursors was delayed in Insm1 mutant mice, and we found that many subtype-specific genes were expressed behind schedule. Sympatho-adrenal precursors subsequently escaped the differentiation block in Insm1 mutant mice, and generated sympathetic neurons that matured correctly. However, secondary sympathetic ganglia in Insm1 mutant mice remained small, owing to a decreased proliferation of the precursors. Sympatho-adrenal precursors also generate chromaffin cells in the adrenal medulla. We observed a marked change in terminal differentiation of chromaffin cells, reduced expression of genes whose protein products control catecholamine synthesis and secretion, and low catecholamine levels in Insm1 mutant mice. Catecholamines are essential for fetal survival and for heart function during development (Lim et al., 2000; Pattyn et al., 2000; Thomas et al., 1995; Zhou et al., 1995) . We were able to rescue the fetal lethality of Insm1 mutant embryos by the administration of catecholamine intermediates. Thus, deficits in catecholamine synthesis are responsible for the reduced viability of Insm1 mutant mice during gestation.
Insm1 and the transcriptional network that regulates sympatho-adrenal differentiation
The transcription factors Phox2a/b, Mash1, Gata2/3 and Hand2 control sympatho-adrenal differentiation, and form a transcriptional network that regulates their own expression as well as the expression of generic and subtype-specific neuronal genes (Goridis and Rohrer, 2002) . Changes in the differentiation of sympatho-adrenal precursors cells were reported for Phox2b, Mash1 and Gata3 mutant mice (Guillemot et al., 1993; Lim et al., 2000; Moriguchi et al., 2006; Pattyn et al., 2006; Pattyn et al., 1999; Tsarovina et al., 2004) . We show here that several factors of the transcriptional network 479 RESEARCH ARTICLE Insm1 in sympatho-adrenal development (Phox2a, Gata3, Mash1) and subtype-specific genes (Th, Dbh) are not correctly expressed during the differentiation of sympathoadrenal precursor cells in Insm1 mutant mice. Conversely, Insm1 expression is not correctly initiated in sympatho-adrenal precursors of Phox2b and Mash1 mutant mice. Insm1 was recently predicted to be a direct Mash1 target (Castro et al., 2006) . Our data are in accordance with a function of Mash1 in the control of Insm1 expression, and demonstrate that Insm1 acts downstream of Phox2b and Mash1 during the development of sympatho-adrenal precursor cells.
Similarities in the phenotypes of Mash1 and Insm1 mutant mice are apparent. For example, in both mutant strains sympatho-adrenal differentiation is correctly initiated, as assessed by Phox2b expression. Phox2a, Gata3, Hand2 and Th transcripts appear behind schedule in all sympatho-adrenal precursor cells of Mash1 mutant mice (Guillemot et al., 1993; Hirsch et al., 1998; Pattyn et al., 2006) . These genes are also expressed delayed in Insm1 mutant mice, but this delay is apparent in the majority, and not all sympatho-adrenal precursors. Finally, in Mash1 mutant mice a block in the differentiation of enteric neurons is present in the esophagus but not in other parts of the gastrointestinal tract (Guillemot et al., 1993; Hirsch et al., 1998; Pattyn et al., 1999) . Similarly, differentiation of esophageal neurons is severely impaired in Insm1 mutant mice, as assessed by the absence Phox2a expression in the esophagus at E10.5 and E18.5; Phox2a is, however, expressed in enteric neurons located in more posterior parts of the enteric nervous system (H.W., M.S.G. and C.B., unpublished). The similarities in phenotypes observed in Mash1 and Insm1 mutant mice suggest that Insm1 mediates aspects of Mash1 functions in the differentiation of catecholaminergic neurons. Mash1 controls generic and subtypespecific aspects of neuronal differentiation of catecholaminergic neurons. Expression of pan-neuronal markers is only mildly affected in Insm1 mutant mice, indicating that Insm1 exerts its role primarily in the control of subtype-specific neuronal differentiation.
In addition, our experiments revealed an upregulated expression of Mash1 and its direct target gene delta-like 1 (Dll1) in sympathoadrenal precursor cells of Insm1 mutant mice. During normal differentiation, Mash1 is expressed transiently in sympatho-adrenal precursor cells. The de-repression of Mash1 might interfere with differentiation of sympatho-adrenal precursors of Insm1 mutant mice. It should be noted that we did not observe upregulated expression of other Notch target genes such as Hes1, Hes5, Hes1r and Nrarp, indicating that upregulated Notch signaling is not responsible for the delayed differentiation. It has previously been noted that the Mash1 promoter is de-repressed in Mash1 mutant mice, but Mash1 does not directly mediate this negative regulation (Meredith and Johnson, 2000) . De-repression of Mash1 was also observed in chromaffin cells of Gata3 mutant mice (Moriguchi et al., 2006) , indicating that the Zn-finger factors Gata3 and Insm1 participate in the regulatory feedback loop that controls Mash1.
Mash1 and Phox2b are the first transcription factors that appear upon initiation of differentiation of sympatho-adrenal precursors (Tsarovina et al., 2004) . Hand2, Phox2a and Gata3 act genetically downstream of Mash1 and Phox2b, but mis-expression of Hand2 and Phox2a induces Mash1 and Phox2b, and Gata3 is required to maintain correct Phox2b expression (Howard et al., 1999; Howard et al., 2000; Lucas et al., 2006; Moriguchi et al., 2006; Stanke et al., 1999; Stanke et al., 2004; Tsarovina et al., 2004) . These transcription factors seem thus to collaborate during specification of the sympatho-adrenal lineage, and despite their sequential appearance during development, they form a regulatory network rather than a linear cascade. We report here changes in the expression of several of these transcription factors in Insm1 mutant mice, which demonstrates that Insm1 is an essential component of the transcriptional network that controls differentiation of sympathoadrenal precursor cells.
Timing of differentiation and execution of the differentiation program
Sympatho-adrenal precursors migrate in order to form secondary sympathetic ganglia, as well as adrenal and extra-adrenal chromaffin cells (Huber, 2006; Unsicker et al., 2005) . Mature sympathetic neurons and chromaffin cells share characteristics, like the expression of Th and Dbh, but they also display distinct features. Sympathetic neurons extend axons and maintain typical neuronal markers such as neurofilament 68 (Nefl), whereas neuronal markers are downregulated in chromaffin cells. The presence of secretory granules and the expression of Pnmt are typical for chromaffin cells and are further properties that distinguish the two cell types. We report here a delayed differentiation of sympatho-adrenal precursor cells in Insm1 mutant mice. Remaining precursor cells of Insm1 mutant mice eventually escape the block, and undergo sympathoadrenal differentiation. During development of sympatho-adrenal precursor cells, Insm1 is thus crucial for the correct timing of differentiation.
Sympatho-adrenal precursors of Insm1 mutant mice subsequently form sympathetic neurons, albeit at reduced numbers. In marked contrast, the further development of chromaffin cells was significantly altered, and enzymes of catecholamine biosynthesis (Th, Dbh, Pnmt) and components of secretory granules (chromogranin A/B) were markedly downregulated, whereas neurofilament (NF68) expression was increased. This was accompanied by an altered morphology of the adrenal medulla, and by increased apoptosis of chromaffin cells. Insm1 is therefore required for the correct execution of the differentiation program of chromaffin cells. Upregulated expression of Mash1 and neurofilament 68 indicate that chromaffin cells retain the character of immature sympatho-adrenal precursors in Insm1 mutant mice. This represents a further similarity in the phenotypes of Mash1 and Insm1 mutant mice [compare Huber et al. (Huber et al., 2002) with this study]. It has previously been proposed that two distinct types of sympatho-adrenal precursors exist in the primary ganglion chain, one population destined to form sympathetic neurons and a second destined to form chromaffin cells (Huber et al., 2002) . Such a hypothesis is supported by the fact that the number of sympathoadrenal cells in the primary ganglion chain is markedly reduced in Insm1 mutant mice, which affects the numbers of sympathetic neurons but not the numbers of chromaffin precursors that arrive in the adrenal gland.
Insm1 is also essential for terminal differentiation of endocrine cells of the pancreas and intestine (Gierl et al., 2006; Mellitzer et al., 2006) . Genetic evidence indicates that Insm1 expression depends on two bHLH transcription factors Ngn3 and Mash1 in the pancreas and sympatho-adrenal cells, respectively, indicating that similar molecular mechanisms function upstream of Insm1 in these distinct organs. Chromaffin cells and endocrine cells of the pancreas and intestine produce different hormones, but they share endocrine characteristics such as the expression of granins. Chromogranin A/B are two genes whose expression is markedly downregulated in chromaffin cells, as well as in endocrine cells of the pancreas and intestine in Insm1 mutant mice. The identification of direct target genes will reveal how Insm1 participates in the execution of a gene expression program that controls endocrine features. During adrenergic differentiation of neurons, Insm1 appears to mediate aspects of Mash1 functions in subtype-specific differentiation. Alternatively, Insm1 and Mash1 might co-operate to control expression of subtype-specific genes in developing peripheral neurons.
